Stock market analysts and brokers have recently amended their target prices on shares of Medivation, Inc. (NASDAQ:MDVN). The most recent analyst ratings issued by brokerages: 09/13/2016 – Medivation, Inc. had …
The stock in the Biotechnology industry, Medivation, Inc. (MDVN) could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the …
Tina provides the U.S. as well as global markets commentary that cover the stock, commodity, and currency markets. She covers latest activity, events and trends, from economic reports and financial indicators relating …
Medivation Inc (NASDAQ:MDVN) tops the list of top biotech stocks with 10-year ... As is often the case with …
Medivation, Inc.
Medivation (MDVN) stock rose 5.7% on December 21, 2015, on news that the company is initiating its Phase 2 trial of MDV9300. According to the press release, MDVN announced “the initiation of an international Phase 2 …
Drugmaker Medivation's (MDVN) stock was jumping Monday -- and lifting some other big biotechs with it -- after Pfizer (PFE) announced that it's acquiring the company for $14 billion in cash. The Pfizer-Medivation deal was …
Medivation, Inc.
(Original Source) Shares of Medivation closed today at $63.45, up $0.27 or 0.43%. MDVN has a 1-year high of …
Pfizer Inc.’s (NYSE:PFE) likely acquisition of Medivation Inc. (NASDAQ:MDVN) is perhaps the hottest development that took place over the weekend. The world’s largest drug maker is said to be acquiring the …
TCC8mon
Biotech stock Medivation Inc (NASDAQ:MDVN) is up 7.4% at $49.12 today, bringing the shares into the black on a year-to-date basis for the first time in 2016, on reports that the company has rebuffed a takeover bid from …